Завантаження

Slzii.com Пошук

Пошук (Новини)

Abivax Presents Q1 2026 Financial Results And Reports Three-Year Interim Data From Study 108, A Phase 2A/2B Open-Label Extension Trial Of Obefazimod Following Dose De-Escalation In Patients With UC

Abivax Presents Q1 2026 Financial Results And Reports Three-Year Interim Data From Study 108, A Phase 2A/2B Open-Label Extension Trial Of Obefazimod Following Dose De-Escalation In Patients With UC
english top business

(MENAFN - EQS Group) ABIVAX / Key word(s): Quarter Results/Study results Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b ...
2026-05-23 01:21:13

що ти робиш
0.10199308395386


Новини
Новини

Останні новини та заголовки
(MENAFN - EQS Group) ABIVAX / Key word(s): Quarter Results/Study results Abivax Presents Q1 2026 Financial Results and Reports Three-Year In...
Новини